A detailed history of Montag & Caldwell, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Montag & Caldwell, LLC holds 1,680 shares of LLY stock, worth $1.55 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
1,680
Previous 746 125.2%
Holding current value
$1.55 Million
Previous $660,000 96.36%
% of portfolio
0.28%
Previous 0.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$727.2 - $932.06 $679,204 - $870,544
934 Added 125.2%
1,680 $1.3 Million
Q2 2022

Aug 09, 2022

BUY
$278.73 - $327.27 $207,932 - $244,143
746 New
746 $242,000
Q3 2020

Nov 06, 2020

SELL
$146.22 - $169.13 $207,632 - $240,164
-1,420 Closed
0 $0
Q2 2020

Aug 03, 2020

SELL
$136.42 - $164.18 $65,481 - $78,806
-480 Reduced 25.26%
1,420 $233,000
Q1 2020

May 01, 2020

BUY
$119.05 - $147.35 $226,195 - $279,965
1,900 New
1,900 $264,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $875B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Montag & Caldwell, LLC Portfolio

Follow Montag & Caldwell, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag & Caldwell, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Montag & Caldwell, LLC with notifications on news.